tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Evan Seigerman, 286 are a BUY (66.51%), 119 are a HOLD (27.67%), 25 are a SELL (5.81%).
Analyst Evan Seigerman, currently employed at BMO, carries an average stock price target met ratio of 69.76% that have a potential upside of 33.2% achieved within 253 days. Previously, Evan Seigerman worked at CREDIT SUISSE.
Evan Seigerman’s has documented 857 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on REPL, Replimune Group at 30-Jun-2026.
Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 10/8/2025. The price target of $72 was fulfilled within 2 days with a profit of $6.7 (10.26%) receiving and performance score of 51.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2023
2 years 7 months 1 days ago
(07-Dec-2023)
0/2 (0%)
$68.1 (94.71%)
Buy Since 05-Nov-2018
$4
$2.87 (253.98%)
$9
4 years 7 months 7 days ago
(01-Dec-2021)
2/2 (100%)
$-8.43 (-67.82%)
670
Buy Since 16-Aug-2018
$4
$2.87 (253.98%)
$7
5 years 3 months 22 days ago
(16-Mar-2021)
3/3 (100%)
$-33.2 (-89.25%)
1106
Sell Since 13-Aug-2020
$16.6
$15.47 (1369.03%)
$16.8
5 years 8 months 2 days ago
(06-Nov-2020)
4/4 (100%)
$-12.4 (-42.76%)
335
Buy Since 09-May-2019
$120
$118.87 (10519.47%)
7 years 1 months 29 days ago
(09-May-2019)
0/1 (0%)
$56.4 (88.68%)
Which stock is Evan Seigerman is most bullish on?
Which stock is Evan Seigerman is most reserved on?
What Year was the first public recommendation made by Evan Seigerman?
